VAV2 and central nervous system cancer: In addition, the analyses of GSE4290 dataset and clinical specimens demonstrated that VAV2 was upregulated in gliomas compared to non-tumors (Figure 7(b)), as noted above, tRFdb-3003a and tRFdb-3003b were down-regulated in gliomas (Figure 1(b)).